SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.44 CNY | -1.23% |
|
-10.81% | -30.48% |
| Sales 2022 | 568M 78.42M | Sales 2023 | 489M 67.53M | Capitalization | 2.96B 408M |
|---|---|---|---|---|---|
| Net income 2022 | 177M 24.43M | Net income 2023 | 112M 15.46M | EV / Sales 2022 | 3.84 x |
| Net cash position 2022 | 1.42B 196M | Net cash position 2023 | 1.42B 196M | EV / Sales 2023 | 3.15 x |
| P/E ratio 2022 |
19.1
x | P/E ratio 2023 |
26.5
x | Employees | 523 |
| Yield 2022 |
1.48% | Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.23% | ||
| 1 week | -10.81% | ||
| Current month | -11.93% | ||
| 1 month | -11.09% | ||
| 3 months | -22.33% | ||
| 6 months | -32.02% | ||
| Current year | -30.48% |
1 week
21.21
24.80
1 month
21.2129.80
Current year
19.6632.82
1 year
19.6645.00
3 years
19.6680.39
5 years
19.6680.39
10 years
19.6680.39
| Managers | Title | Age | Since |
|---|---|---|---|
Xiang Yun Qian
CEO | Chief Executive Officer | 54 | 00-10-31 |
Yi Qian
CHM | Chairman | 49 | 10-02-28 |
Ai Jin Bian
DFI | Director of Finance/CFO | 38 | 14-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ying Xian Shen
BRD | Director/Board Member | 38 | 19-09-11 |
Jia Sheng Tu
BRD | Director/Board Member | 60 | 22-09-08 |
Zhong Chen
BRD | Director/Board Member | 61 | 22-09-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 22.44 | -1.23% | 1,925,253 |
| 24-04-25 | 22.72 | +1.02% | 1,724,985 |
| 24-04-24 | 22.49 | +1.03% | 1,856,428 |
| 24-04-23 | 22.26 | -8.43% | 3,069,666 |
| 24-04-22 | 24.31 | -3.38% | 1,759,209 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Suzhou Fushilai Pharmaceutical Co Ltd is a China-based company mainly engaged in the production and sales of pharmaceuticals. The Company is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and raw materials for health care products. The Company's main products include three series of lipoic acid series, phosphatidylcholine series and carnosine series. The Company mainly conducts its business in domestic and overseas markets such as Europe, America, Japan and South Korea, India and South America.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -30.48% | 284M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 301258 Stock
